Adagio Medical Holdings, Inc. (ADGM) - Dilution Analysis

10-Q filing | 22.2M shares outstanding

POS AM filing: This POS AM filing relates to the potential resale of common stock by selling stockholders, as well as the potential issuance of common stock upon the exercise of warrants and conversion of convertible notes.

POS AM filing: This POS AM filing relates to the potential resale of common stock by selling stockholders, including shares issuable upon conversion of convertible notes and exercise of warrants.

10-K filing | 22.2M shares outstanding

10-Q filing | 15.4M shares outstanding

10-Q filing | 15.4M shares outstanding

10-K filing | 15.2M shares outstanding

S-1/A filing: This S-1/A filing registers shares of common stock for resale by selling stockholders, including shares issuable upon conversion of convertible notes and exercise of warrants.

S-1/A filing: This S-1/A filing registers for resale shares of common stock held by selling stockholders, including shares issuable upon exercise of warrants and conversion of convertible notes.

S-1 filing: This S-1 filing registers up to 31,145,320 shares of common stock issuable upon conversion of notes and up to 600,000 shares of common stock issuable upon exercise of warrants by selling stockholders.

S-1 filing: This S-1 filing registers for resale shares of common stock held by selling stockholders, including shares issuable upon exercise of warrants and conversion of convertible notes.

8-K filing: Adagio Medical Holdings, Inc. entered into a Limited Waiver and Amendment to its Securities Purchase Agreement, Registration Rights Agreement, and promissory notes, with Buyers, waiving certain defaults and allowing for payment of the Registration Delay Payment in restricted shares at $2.00 per share, issuing 183,333 Restricted Shares.

POS AM filing: This is a POS AM filing for the offer, sale or other disposition from time to time of up to 32,993,796 shares of common stock by the selling stockholders.

POS AM filing: This prospectus relates to the offer, sale or other disposition from time to time of up to 8,505,387 shares of our common stock by the selling stockholders.

10-Q filing | 14.5M shares outstanding

POS AM filing: This prospectus relates to the offer, sale or other disposition from time to time of up to 8,505,387 shares of our common stock by the selling stockholders.

POS AM filing: This POS AM filing relates to the offer, sale or other disposition from time to time of up to 32,993,796 shares of common stock by the selling stockholders.

S-1 filing: This S-1 filing relates to the offer and sale of up to 8,505,387 shares of common stock by selling stockholders, consisting of shares issuable upon conversion of convertible notes and exercise of warrants.

S-1 filing: This prospectus relates to the offer, sale or other disposition from time to time of up to 32,993,796 shares of our common stock by the selling stockholders named in this prospectus or their permitted transferees.

10-Q filing | 13.4M shares outstanding

8-K filing: ListCo amended subscription agreements with PIPE Investors, increasing Sponsor Promote Allocation Shares and Additional Cash. New Adagio issued shares, Base Warrants, and Pre-Funded Warrants to PIPE Investors, and Convertible Notes and Convert Warrants to Convert Investors. ($62.8M proceeds)